4.5 Article

Glutathione peroxidase-1 protects against cigarette smoke-induced lung inflammation in mice

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajplung.00038.2010

Keywords

oxidative stress; reactive oxygen species; leukocyte; proteases; macrophage growth factors

Funding

  1. National Health and Medical Research Council of Australia

Ask authors/readers for more resources

Duong C, Seow HJ, Bozinovski S, Crack PJ, Anderson GP, Vlahos R. Glutathione peroxidase-1 protects against cigarette smoke-induced lung inflammation in mice. Am J Physiol Lung Cell Mol Physiol 299: L425-L433, 2010. First published May 28, 2010; doi:10.1152/ajplung.00038.2010.-Reactive oxygen species (ROS) produced from cigarette smoke cause oxidative lung damage including protein denaturation, lipid peroxidation, and DNA damage. Glutathione peroxidase-1 (gpx-1) is a detoxifying enzyme that may protect lungs from such damage. The aim of this study was to determine whether gpx-1 protects the lung against oxidative stress-induced lung inflammation in vivo. Male wild-type (WT) or gpx-1(-/-) mice were exposed to cigarette smoke generated from nine cigarettes per day for 4 days to induce oxidative stress and lung inflammation. The effect of the gpx mimetic ebselen on cigarette smoke-induced lung inflammation was evaluated when given prophylactically and therapeutically, i.e., during established inflammation. Mice were killed, and the lungs were lavaged with PBS and then harvested for genomic and proteomic analysis. Gpx-1(-/-) mice exposed to cigarette smoke had enhanced BALF neutrophils, macrophages, proteolytic burden, whole lung IL-17A, and MIP1 alpha mRNA compared with WT mice. The gpx mimetic ebselen (10 and 100 mu M) inhibited cigarette smoke extract-induced oxidation of MH-S cells in vitro and inhibited cigarette smoke-induced increases in BALF macrophages, neutrophils, proteolytic burden, and macrophage and neutrophil chemotactic factor gene expression when administered prophylactically. In addition, ebselen inhibited established BALF inflammation when administered therapeutically. These data show that gpx-1 protects against cigarette smoke-induced lung inflammation, and agents that mimic the actions of gpx-1 may have therapeutic utility in inflammatory lung diseases where cigarette smoke plays a role.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Biochemistry & Molecular Biology

SPLUNC1 α6 Peptidomimetic: A Novel Therapeutic for Asthma

Ross Vlahos

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2022)

Article Critical Care Medicine

Longitudinal Association Between Muscle Loss and Mortality in Ever Smokers

Stefanie E. Mason, Rafael Moreta-Martinez, Wassim W. Labaki, Matthew J. Strand, Elizabeth A. Regan, Jessica Bon, Ruben San Jose Estepar, Richard Casaburi, Merry-Lynn McDonald, Harry B. Rossiter, Barry Make, Mark T. Dransfield, MeiLan K. Han, Kendra Young, Jeffrey L. Curtis, Kathleen Stringer, Greg Kinney, John E. Hokanson, Raul San Jose Estepar, George R. Washko

Summary: The longitudinal loss of fat-free mass (FFM) is associated with increased all-cause mortality, regardless of initial body composition metrics, including BMI or muscle mass. This finding may improve risk stratification and identify novel therapeutic targets for patients with chronic obstructive pulmonary disease.

CHEST (2022)

Article Oncology

Programmed Death-Ligand 1 Copy Number Loss in NSCLC Associates With Reduced Programmed Death-Ligand 1 Tumor Staining and a Cold Immunophenotype

Savreet Aujla, Christian Aloe, Amanda Vannitamby, Shona Hendry, Kanishka Rangamuwa, Hao Wang, Ross Vlahos, Stavros Selemidis, Tracy Leong, Daniel Steinfort, Steven Bozinovski

Summary: This study investigated the variations of PD-L1 gene copy number in NSCLC and its relationship with PD-L1 tumor cell staining and inflammatory gene expression. The results showed that PD-L1 copy number was positively correlated with PD-L1 tumor cell staining and associated with reduced levels of inflammatory and immunosuppressive mediators in tumors with low PD-L1 copy number. The analysis of bronchoscopy-derived biopsies showed low heterogeneity in copy number values across different anatomical sites.

JOURNAL OF THORACIC ONCOLOGY (2022)

Article Microbiology

Influenza A virus elicits peri-vascular adipose tissue inflammation and vascular dysfunction of the aorta in pregnant mice

Osezua Oseghale, Stella Liong, Madison Coward-Smith, Eunice E. To, Jonathan R. Erlich, Raymond Luong, Felicia Liong, Mark Miles, Shaghayegh Norouzi, Cara Martin, Sharon O'Toole, Robert D. Brooks, Steven Bozinovski, Ross Vlahos, John J. O'Leary, Doug A. Brooks, Stavros Selemidis

Summary: Influenza A virus infection during pregnancy leads to dysfunction in aortic endothelial cells and vascular smooth muscle, with the perivascular adipose tissue (PVAT) playing a role in viral dissemination and inflammation. The PVAT exhibits increased levels of inflammatory cells and activated T cells along with increased neutrophils, pro-inflammatory cytokines, and oxidative stress markers.

PLOS PATHOGENS (2022)

Article Biochemistry & Molecular Biology

Glycolysis and the Pentose Phosphate Pathway Promote LPS-Induced NOX2 Oxidase- and IFN-β-Dependent Inflammation in Macrophages

Jonathan R. Erlich, Eunice E. To, Raymond Luong, Felicia Liong, Stella Liong, Osezua Oseghale, Mark A. Miles, Steven Bozinovski, Robert D. Brooks, Ross Vlahos, Stanley Chan, John J. O'Leary, Doug A. Brooks, Stavros Selemidis

Summary: The study reveals that macrophages undergo a metabolic switch from oxidative phosphorylation to glycolysis when exposed to gram-negative bacterial lipopolysaccharide (LPS). This switch modulates antibacterial host defence mechanisms by increasing the activity of NOX2 enzyme and promoting the expression of type I IFN-beta. Both glycolysis and the pentose phosphate pathway play important roles in promoting LPS-induced inflammation in macrophages.

ANTIOXIDANTS (2022)

Article Multidisciplinary Sciences

Cross-talk between IL-6 trans-signaling and AIM2 inflammasome/IL-1β axes bridge innate immunity and epithelial apoptosis to promote emphysema

Saleela M. Ruwanpura, Louise McLeod, Lovisa F. Dousha, Huei J. Seow, Alison C. West, Alice J. West, Teresa Weng, Mohammad Alanazi, Martin MacDonald, Paul T. King, Philip G. Bardin, Cem Gabay, Dennis M. Klinman, Steven Bozinovski, Ross Vlahos, Gary P. Anderson, Stefan Rose-John, Mohamed I. Saad, Brendan J. Jenkins

Summary: Pulmonary emphysema is associated with dysregulated innate immune responses. In this study, the authors investigated the role of innate immune inflammasome complexes in promoting emphysema. They found that ASC, Caspase-1, and AIM2 were up-regulated in emphysematous patients and mouse models of emphysema. AIM2 was associated with elevated levels of IL-1 beta. Blockade of AIM2 and IL-1 receptor ameliorated emphysema in mice. IL-6 trans-signaling was also found to augment AIM2 expression in emphysema.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Physiology

Cigarette smoke depletes alveolar macrophages and delays clearance of Legionella pneumophila

Markus Fleischmann, Andrew G. Jarnicki, Andrew S. Brown, Chao Yang, Gary P. Anderson, Natalio Garbi, Elizabeth L. Hartland, Ian R. van Driel, Garrett Z. Ng

Summary: Cigarette smoke exposure depletes alveolar macrophages and increases the severity of Legionnaires' disease, while these macrophages play a major role in bacterial clearance.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2023)

Article Allergy

Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthma

Gabriele Matschiner, Mary F. Fitzgerald, Ulrich Moebius, Andreas M. Hohlbaum, Hendrik Gille, Kristian Jensen, Klaus Kirchfeld, Barbara Rattenstetter, Alice Laforge, Rachida S. Bel Aiba, Joe Ciccotosto, Hong Nyugen, Martyn L. Foster, John N. Snouwaert, MyTrang Nguyen, Beverly H. Koller, Louis Matis, Gary P. Anderson, Shane A. Olwill

Summary: The study reengineered Lcn1 into an inhalable IL-4Ra antagonist, named PRS-060, and evaluated its pharmacodynamic/kinetic profile. This antagonist competitively antagonized IL-4Ra-dependent cell proliferation, mucus induction, and eotaxin expression in vitro. In a triple-humanized mouse model, PRS-060 strongly suppressed acute allergic inflammation indexes, suggesting its potential as a treatment for type 2 endotype asthma.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Article Biochemistry & Molecular Biology

Enhanced Lyn Activity Causes Severe, Progressive Emphysema and Lung Cancer

Evelyn Tsantikos, Timothy A. Gottschalk, Elan L'Estrange-Stranieri, Caitlin A. O'Brien, April L. Raftery, Lakshanie C. Wickramasinghe, Jonathan L. McQualter, Gary P. Anderson, Margaret L. Hibbs

Summary: The epidemiological patterns of COPD and lung adenocarcinoma are changing, with a growing number of cases occurring in non-smokers or individuals not exposed to traditional risk factors. The exact causative mechanisms are still unclear, but overactivity of SFKs and inflammatory lung damage are potential candidates. A preclinical model involving Lyn mutation has shown that it causes spontaneous inflammation, emphysema, and lung adenocarcinoma, providing new insights into the pathogenesis of these diseases.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2023)

Article Allergy

Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

Rod Hughes, Eleni Rapsomaniki, Aruna T. Bansal, Jorgen Vestbo, David Price, Alvar Agusti, Richard Beasley, Malin Fageras, Marianna Alacqua, Alberto Papi, Hana Mullerova, Helen K. Reddel

Summary: Cluster analysis in patients with asthma and/or COPD identified distinct clusters with characteristics that differed from conventional diagnostic features. The overlap between clusters suggests that they do not reflect discrete underlying mechanisms.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)

Article Allergy

Safety and Effectiveness of As-Needed Formoterol in Asthma Patients Taking Inhaled Corticosteroid (ICS)-Formoterol or ICS-Salmeterol Maintenance Therapy

Helen Kathryn Reddel, Guy Brusselle, Rosa Lamarca, Per Gustafson, Gary P. Anderson, Carin Jorup

Summary: This study aimed to evaluate the safety and effectiveness of as needed formoterol in patients taking maintenance ICS-formoterol or ICS-salmeterol. The results showed that as-needed formoterol significantly reduced exacerbation risk in patients on maintenance ICS-formoterol but not in patients on maintenance ICS-salmeterol.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)

Article Pathology

Granulocyte Colony-Stimulating Factor is a Determinant of Severe Bronchopulmonary Dysplasia and Coincident Retinopathy

Lakshanie C. Wickramasinghe, Evelyn Tsantikos, Alida Kindt, April L. Raftery, Timothy A. Gottschalk, Jessica G. Borger, Atul Malhotra, Gary P. Anderson, Peter van Wijngaarden, Anne Hilgendorff, Margaret L. Hibbs

Summary: This study found that granulocyte colony-stimulating factor (G-CSF) plays a pathological role in bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP). The deficiency of G-CSF can partially protect the lung and retina from injury.

AMERICAN JOURNAL OF PATHOLOGY (2023)

Article Respiratory System

Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD

Erin L. Tomaszewski, Mark J. Atkinson, Christer Janson, Niklas Karlsson, Barry Make, David Price, Helen K. Reddel, Claus F. Vogelmeier, Hana Mullerova, Paul W. Jones

Summary: The Chronic Airways Assessment Test (CAAT), a questionnaire adapted for patients with asthma and/or COPD, has been shown to be consistent and accurate in measuring overall health status in these patients.

RESPIRATORY RESEARCH (2023)

Article Respiratory System

Prime-boost, double-dose influenza vaccine immunity in COPD: a pilot observational study

Gary P. Anderson, Louis B. Irving, Andrew Jarnicki, Katherine Kedzierska, Marios Koutsakos, Stephen Kent, Aeron C. Hurt, Adam K. Wheatley, Thi H. O. Nguyen, Natale Snape, John W. Upham

Summary: This study conducted a vaccine trial on 33 COPD patients and found that double-dose immunization with the seasonal influenza vaccine did not further improve the immune response in previously vaccinated patients. These findings highlight the need for more effective vaccine strategies for COPD patients.

ERJ OPEN RESEARCH (2023)

Meeting Abstract Critical Care Medicine

Development of TLR2/6 Agonist (INNA-051) to Protect the Elderly Against Respiratory Virus Infection

G. P. Anderson, A. Jarnicki, S. Loo, J. Ciccotosto, J. Girkin, R. O'Donoghue, F. Mercuri, N. W. Bartlett

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

No Data Available